The University of Iowa

State Hygienic Laboratory

Breadcrumb

  1. Home
  2. Testing Specialties
  3. Diagnostic and Clinical Testing

Test Detail


Blood Lead Screening-Venous Sample Follow-up

Back to Test Directory
Test Description
  • Contact: Blood Lead (515) 725-1600
  • Test Request Form: Blood Lead
  • SHL OpenELIS Code: 601
Blood Lead Screening-Venous Sample Follow-up is a confirmatory test when an initial finger stick sample is ≥ 15 µg/dL.
Reflex Test(s)
Reflex test from initial Blood Lead Screening if result is ≥ 15 µg/dL
Performed Avg. Turnaround Time Method
Ankeny, 8 a.m. - 5 p.m., M-F
1 - 5 business days Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
Fee CPT Code(s)
$24.32 83655
Specimen Requirements
Specimen Type: Whole blood. Venous sampling is required when an initial finger stick sample is ≥ 15 µg /dL.
Collection Instructions: Venous Collection:
  1. Collect venous blood samples in a lavender top EDTA or pink top K2EDTA tube.
  2. MIX WELL to allow anti-coagulant (EDTA) to work. Clotted specimens cannot be analyzed.
Shipping:
Wrap specimen container in absorbent material and place inside a biohazard bag. Place the bag into the Styrofoam container, then into the cardboard mailer. Transport specimen at room temperature. Ship to the Ankeny location.
Temperature and Stability: Room Temperature; stable for 30 days
Rejection Criteria: Specimens will be rejected if received under these conditions:

Heparin anticoagulant. Clotted specimens.
Expected Results:
Value in µg/dL
Comments
Confirmation of elevated levels of blood lead from initial screening. Specimen should be collected in a lead-free tube. Must identify whether capillary or venous specimen.
Alternate Names
Blood lead screening; Blood lead confirmation; lead, blood
The University of Iowa

State Hygienic Laboratory

General inquires
SHL Client Services
319-335-4500 or 1-800-421-IOWA (4692)
ask-shl@uiowa.edu

Footer primary

  • HIPAA Notice of Privacy Practice
  • Copyright 2025 The University of Iowa
  • Privacy Notice
  • UI Nondiscrimination Statement
  • Accessibility